Variable PD-1 glycosylation modulates the activity of immune checkpoint inhibitors
Article in Life Science Alliance (January 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Reactive cutaneous capillary endothelial proliferation following camrelizumab monotherapy or combination therapy for multi-cancers: a large-scale pooled analysis of 10 studies in China
Article in Therapeutic Advances in Medical Oncology (January 2024)
Efficacy and safety of camrelizumab combined with apatinib for the second-line treatment of advanced gastric cancer
Article in Cancer Research and Clinic (October 2023)